# Pacemaker Holter Assessment of the Effect of BMS-914392 on Atrial Fibrillation Burden

> **NCT01356914** · PHASE2 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 20 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** BMS-914392
- **DRUG:** BMS-914392
- **DRUG:** BMS-914392
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01356914
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01356914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01356914, "Pacemaker Holter Assessment of the Effect of BMS-914392 on Atrial Fibrillation Burden". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01356914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*